Article
Association of HLA genotypes, AB0 blood type and chemokine receptor 5 mutant CD195 with the clinical course of COVID-19.
European journal of medical research - 16 Sept 2021
Fischer Johannes C, Schmidt Albrecht G, Bölke Edwin, Uhrberg Markus, Keitel Verena, Feldt Torsten, Jensen Björn, Häussinger Dieter, Adams Ortwin, Schneider E Marion, Balz Vera, Enczmann Jürgen, Rox Jutta, Hermsen Derik, Schulze-Bosse Karin, Kindgen-Milles Detlef, Knoefel Wolfram Trudo, van Griensven Martijn, Haussmann Jan, Tamaskovics Balint, Plettenberg Christian, Scheckenbach Kathrin, Corradini Stefanie, Pedoto Alessia, Maas Kitti, Schmidt Livia, Grebe Olaf, Esposito Irene, Ehrhardt Anja, Peiper Matthias, Buhren Bettina Alexandra, Calles Christian, Stöhr Andreas, Lichtenberg Artur, Freise Noemi F, Lutterbeck Matthias, Rezazadeh Amir, Budach Wilfried, Matuschek Christiane
Abstract excerpt
BACKGROUND: COVID-19, the pandemic disease caused by infection with SARS-CoV-2, may take highly variable clinical courses, ranging from symptom-free and pauci-symptomatic to fatal disease. The goal of the current study was to assess the association of COVID-19 clinical courses controlled by patients' adaptive immune responses without progression to severe disease with patients' Human Leukocyte Antigen (HLA)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
